Mark Cuban Slams U.S. Plan To Give Chinese Billionaire Monopoly On Cancer Drug | WHAT REALLY HAPPENED


Mark Cuban Slams U.S. Plan To Give Chinese Billionaire Monopoly On Cancer Drug

Mark Cuban on Wednesday condemned a federal agency’s plan to give a pharmaceutical company controlled by a Chinese billionaire exclusive rights to a new liver cancer treatment developed with U.S. government researchers.

The Dallas Mavericks owner, himself a billionaire, told HuffPost the decision “ignored” the need to use taxpayer-funded research in a way that advantages Americans.

“USA inc has got to start operating in the best interests of all of us shareholders,” the “Shark Tank” host wrote in an email, after retweeting a link to a HuffPost report on the licensing plans. “Our taxes should be an investment that expects a financial and social return.”

The National Institutes of Health proposed awarding Salubris Biotherapeutics Inc. exclusive worldwide rights to a portfolio of patents on an antibody drug used to treat liver cancer, according to a notice published Monday in the Federal Register, first reported by HuffPost.

Webmaster's Commentary: 

The question is, why would the NIH give the rights to this drug to this particular company, when it was developed by U.S. government researchers?!?

This status of the award needs to be halted, and a complete investigation of how it is that a Chinese owned company was awarded the rights to this drug, needs a full and complete investigation.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA